Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE JAPAN EDITION 2026

Japan’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Japan. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Japan
JP
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Japan’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Japan, snapshot 1 September 2026
Company
WHILLwhill.inc$107.5M—300—
Atonarpatonarp.com$107M—74—
Kamui Pharmakamuipharma.co.jp$96.26M———
Megakaryomegakaryon.com$91.5M—11—
Aculysaculys.com$84M—12—
RaQualiaraqualia.com$84M———
ThinkCytethinkcyte.com$83.18M—33—
Heartseedheartseed.jp$76.73M—12—
Stelicstelic.com—10 roles21—
canon medical systemsglobal.medical.canon—5 roles520—
Metcelametcela.com—2 roles7—
Celaid Therapeuticscelaidtx.com—1 roles8—
Kyowa Kirinkyowa-kirin.com—1 roles724—
Life Analyticslifeanalytics.org—1 roles——
PHC Holdingsphchd.com—1 roles3—
agathaagathalife.com—1 roles39—
BMLbml.co.jp——9,005—
Daiichi Sankyodaiichisankyo.com——32,791—
Euglenaeuglena.jp——1,070—
Genequestgenequest.jp————
Kissei Pharmaceuticalkissei.co.jp——1,359—
Kyowa Kirinkyowakirin.com——928—
Olympusolympus-global.com——35,933Financial figure available in RadarView in Radar
Shimadzu Corporationshimadzu.com——15,284—
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Life Sciences industry KPIs in Japan

A few useful ratios bring the size of this ecosystem into perspective.

1 September 2026
Hiring participation1.5%

11 of 732 tracked companies have open roles.

Funding participation33.2%

243 of 732 tracked companies have a recorded round.

Top 3 funding share12.7%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$4.57M

Midpoint of 256 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 12.7% of disclosed capital, while 66.8% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Japan life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Japan life sciences
$0$96.86M$193.73M$290.59M$387.46M2016: $97.02M20162017: $140.9M20172018: $165.37M20182019: $160.93M20192020: $90.88M20202021: $295.11M20212022: $339.87M20222023: $190.29M20232024: $294.16M20242025: $219.62M2025
View the numbers
Annual life sciences funding and company formation in Japan
YearFunding (USD)FoundedRaising
2016$97.02M5011
2017$140.9M4518
2018$165.37M6024
2019$160.93M4315
2020$90.88M3712
2021$295.11M3526
2022$339.87M2029
2023$190.29M629
2024$294.16M934
2025$219.62M133
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • WHILL4.4%
  • Atonarp4.4%
  • Kamui Pharma3.9%
  • Other companies87.3%

Funding by stage

395 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel143 36.2%
Series A–B178 45.1%
Series C+ / PE53 13.4%
Grants, debt & other21 5.3%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Series A04/2026
Restore Vision $8.18M

Backed by Higin Capital and Kyoto University Innovation Capital and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series A10/2021
Aculysaculys.com$60M

Backed by SoftBank Vision Fund and Catalys Pacific and others.

Series D06/2024
WHILLwhill.inc$45M

Backed by SBI Investment and Daiwa PI Partners and others.

Series C09/2018
WHILLwhill.inc$45M

Backed by SBI Investment and Daiwa PI Partners and others.

Series C06/2021
Heartseedheartseed.jp$36.53M

Backed by UTokyo Innovation Platform and Medical Incubator Japan and others.

Series D03/2024
Aillisaillis.jp$33.01M

Participating investors were not recorded in this snapshot.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

No reviewed exact national-ID connector has yet been qualified for Japan; this is a checked implementation boundary, not evidence that filings are absent.; No reviewed exact national-ID connector has yet been qualified for Japan; this is a checked implementation boundary, not evidence that filings are absent.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Japan companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Busiest websites

9 of the 732 companies on this page carry a measured traffic record (1.2%); these are the largest of those, by monthly visits. The median among them is 149,262 visits.

Visits and authority are third-party web estimates, not company-reported figures.

Most-installed apps

26 of these companies (3.6%) publish at least one Android app — 39 apps in all, carrying 5.4M installs between them.

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2024Q2).

SegmentAppsInstallsLeading appRelease trend
Wearable Technology55MOMRON Connect 5M
Cardiac And Vascular Disorders25M血管ナビ 7.6K
Healthcare It25MOh my teeth - Camera 2.9K
Fitness & Wellness Tech25Mフードカレンダー 2
Life Sciences Platforms And Tools4266.9Kヘルスケア手帳 - 電子お薬手帳アプリ 236.7K
Genomics1073.7K遺伝子博士ダイエット 67.1K
Clinical Genomics472.2K遺伝子博士エイジングケア(スカルプ・スキン) 2.9K
Assistive Tech523.9Kみんなの聴脳力チェック 10.9K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

INSIDE THE INDUSTRY

The Japan life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech454
Biopharmaceuticals143
Medical devices133
Deep tech121
Consumer digital72
Enterprise software64
In vitro diagnostics29
Nutritional formula19
Saas18
Life sciences analytics18
Cancer immunotherapy16
Chronic disease management14

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

454companies
2.0%have hiring activity

9 companies hiring · $2.03B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce404
E-commerce - product333
Subscription165
Fee-for-service146
Commission on transaction26
Advertising21
E-commerce - service10
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundssonire-therapeutics.com ↗

Sonire Therapeutics Raises $18M Series A for Focused Ultrasound Therapy in Pancreatic Cancer

Funding roundsrestore-vis.com ↗

Shionogi & Co., Ltd. today announced that it has made an equity investment in Restore Vision Inc.

Mergers & acquisitionslivtech.co.jp ↗

LivTech, a comprehensive healthcare tech provider for long-term post-acute care (LTPAC), has acquired Alora Healthcare Systems, a premier developer of cloud-based, AI-enhanced home health software.

Mergers & acquisitionsnxera.life ↗

An investment could enable a potential merger between Nxera and STT GDC in the long haul, “to create a global player with large scale”.

Funding roundssmart-tissues.com ↗

Each company received ¥24 million in pre-seed funding through Antler’s Inception Residency model.

Mergers & acquisitionsnoritsu.co.jp ↗

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XI, L.P. has entered into a definitive agreement to sell SENQCIA Corporation (“SENQCIA”), a leading provider of mission-critical building products and solutions in Japan, to Noritsu Koki Co., Ltd., in a transaction that represents a total enterprise value of approximately $519 million.

Mergers & acquisitionsshimadzu.com ↗

Global law firm White & Case LLP has advised Carlyle on its agreement to sell Tescan Group to Shimadzu Corporation.

Mergers & acquisitionsraqualia.com ↗

HK inno.N said Monday it has struck a deal with Japan’s RaQualia Pharma to acquire the Japan rights to its acid reflux drug K-CAB (tegoprazan), used to treat gastroesophageal reflux disease, or GERD, a chronic condition in which stomach acid repeatedly flows back into the esophagus.

Mergers & acquisitionsterumo.com ↗

Terumo bought U.K. organ transplant company OrganOx in August.

Mergers & acquisitionsaculys.com ↗

On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc.

Full recorded event mix

Top 10 categories among 178 recorded events in the 24-month window.

Leadership moves
51
Contracts
26
Mergers & acquisitions
24
Funding rounds
20
Earnings
16
Lawsuit
11
Asset acquisitions
7
Regulatory
6
IPO activity
5
Capital infusions
4
6 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

2 companies with recorded IPO activity

Rigaku ↗

IPO · Tokyo Stock Exchange9 reports

IPO · Tokyo Stock Exchange1 reports

Leadership moves

15 tracked people moves

LivTech ↗
Tracy Kim

Appointment Chief Marketing Officer

LivTech ↗
Natalie Shipley

Appointment Chief Revenue Officer

LivTech ↗
Andrew Goode

Appointment Vice President of Development

John Tsai, M.D.

Appointment global head of R&D

Ken Takeshita

Resignation Previously Global Head of R&D

Olympus ↗
Yasuo Takeuchi

Appointment Acting Chief Executive Officer

Olympus ↗
Bob White

Appointment Chief Executive Officer

Olympus ↗
Stefan Kaufmann

Resignation Previously Chief Executive Officer

Workforce actions

1 companies with reported reductions

Olympus ↗

2,000 rolescost reduction

Litigation

15 tracked suits

Company
Northern TK Venture Pte Ltd v daiichi sankyo

stock transaction disputeCivil · Ongoing

Company
olympus v united fiber & data

commission disputeCivil · Filed

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
LivTech→alora healthcare systemsAnnounced2026-04-16Not stated in snapshot
st telemedia global data centres (stt gdc)→Nxera ↗Rumored2026-02-03Not stated in snapshot
kkr→Nxera ↗Completed2026-02-03Not stated in snapshot
Noritsu Koki→senqciaAnnounced2026-01-14$519.0M
Shimadzu Corporation→Tescan GroupAnnounced2026-01-07$850.0M
HK inno.N→RaQualia ↗Announced2025-12-15Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

1 postings in the preceding 12 months. The full 1-posting snapshot covers 1 employers.

Expand panel +

Most advertised job titles

Evaluator Subject Matter Experts Chemistry And Pharmaceutical Sciences1
0 internship postings

0 tracked postings mention remote work.

THE PEOPLE BUILDING THE FIELD

Founders and leaders

382 founders and chief executives across 313 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

25 profiles with education records.

The University of Tokyo
7
Keio University
2
Columbia University
2
Stanford University
2
University of California (Berkeley)
2
INSEAD
2
Nagoya University
2
Columbia Business School
1

Prior employers

5 profiles with prior-work records.

Goldman Sachs
2
Bain
1
McKinsey
1
Morgan Stanley
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

465,222 articles in the measured 12-month window.

Expand panel +
465,222articles in the measured year
98,386articles in 2026Q1
49.0%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Japan · articles per complete quarter

052,989105,977158,966211,9542021Q2: 64,9072021Q22021Q3: 83,5552021Q4: 57,7402022Q1: 70,2222022Q2: 68,5642022Q22022Q3: 71,9922022Q4: 95,9822023Q1: 96,6002023Q2: 95,3132023Q22023Q3: 110,1232023Q4: 89,3492024Q1: 106,6162024Q2: 106,8852024Q22024Q3: 115,1002024Q4: 116,5392025Q1: 142,3062025Q2: 105,4392025Q22025Q3: 184,3082025Q4: 84,1892026Q1: 98,3862026Q1
View quarterly article counts
QuarterArticles
2021Q264,907
2021Q383,555
2021Q457,740
2022Q170,222
2022Q268,564
2022Q371,992
2022Q495,982
2023Q196,600
2023Q295,313
2023Q3110,123
2023Q489,349
2024Q1106,616
2024Q2106,885
2024Q3115,100
2024Q4116,539
2025Q1142,306
2025Q2105,439
2025Q3184,308
2025Q484,189
2026Q198,386

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
121,661 positive · 35,234 neutral · 63,983 negative
2022
165,579 positive · 54,584 neutral · 86,293 negative
2023
232,203 positive · 66,648 neutral · 92,072 negative
2024
241,586 positive · 101,220 neutral · 101,790 negative
2025
252,627 positive · 157,819 neutral · 105,233 negative

Leading coverage topics

Life Sciences coverage across Japan · ranked by full-period article count.

International And Transnational Geographic Entities300,235 articles in the full recorded period
108,090 recent · 81,384 prior
Geopolitical Disputes And Contested Areas300,231 articles in the full recorded period
108,088 recent · 81,383 prior
Administrative And Political Subdivisions300,183 articles in the full recorded period
108,072 recent · 81,367 prior
International Sports Competitions36,970 articles in the full recorded period
6,751 recent · 7,500 prior
International Political Relations36,381 articles in the full recorded period
8,093 recent · 7,182 prior
Olympic Games Coverage26,338 articles in the full recorded period
3,540 recent · 5,768 prior
International Relations And Diplomacy25,349 articles in the full recorded period
5,129 recent · 5,062 prior
Security And Defense Policies24,558 articles in the full recorded period
5,639 recent · 4,673 prior
Trade Policies And Agreements23,376 articles in the full recorded period
9,636 recent · 7,475 prior
Trade Wars And Geopolitical Impacts17,941 articles in the full recorded period
6,267 recent · 5,239 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Japan

KeywordRecentPriorChange
countries4,1931,858126%
trade dispute mechanisms2,7041,72557%
bilateral trade2,3891,40370%
preferential tariff1,8491,27145%
forex liquidity1,620407298%
tariff rate quota1,52397257%
exchange rates1,51388272%
mfn tariff1,38591751%
gold spot price1,212180573%
usd/jpy1,06360975%
honda forums02,596-100%
olympic team selections8351,896-56%
olympic trials8881,616-45%
summer olympics athletics2301,095-79%
sports in summer olympics156930-83%

Event and signal lenses

Life Sciences coverage across Japan

All complete annual cohorts shown
Rising

Regulatory Risk

776,404 classified articles

territories, disputed islands, countries

24.5% critical · 16.5% positive
Rising

Funding Momentum

73,902 classified articles

inflation reports fx, currency intervention policies, trade deficits fx

41.0% critical · 43.6% positive
Rising

Growth

213,800 classified articles

gdp growth rate, gdp acceleration, economic output growth

33.4% critical · 45.7% positive

Life Sciences coverage across Japan. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
—India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Researchers discuss challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and consumer health.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
Gene Expression and mRNA TherapeuticsCommon problems researchers identify · 03

Gene Expression and mRNA Therapeutics

711 papers

15.8% of this theme group

Studies examine hurdles in controlling gene activity, mRNA delivery, and cell‑culture models for medicine.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Research points to difficulties in improving nutrient uptake, breeding efficiency, and resilient food supplies.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease Management and Pest ResistanceCommon problems researchers identify · 05

Plant Disease Management and Pest Resistance

691 papers

15.3% of this theme group

Works address obstacles in innate immunity, pathogen interactions, and integrated pest‑control strategies.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Authors flag the spread of drug‑resistant microbes in humans, livestock, and the environment.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological and Chemical TopicsCommon problems researchers identify · 07

Miscellaneous Biological and Chemical Topics

423 papers

9.4% of this theme group

Papers cover a range of unrelated scientific themes, indicating broader disciplinary noise.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative Stress AssaysCautions · 01

Cellular Toxicity and Oxidative Stress Assays

379 papers

21.5% of this theme group

Studies caution about interpreting in‑vitro and in‑vivo stress measurements for safety evaluation.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection and Trait Prediction LimitsCautions · 02

Genomic Selection and Trait Prediction Limits

257 papers

14.6% of this theme group

Research warns of uncertainties when applying genomic tools to plant breeding and animal production.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and Human Dietary ShiftsCautions · 03

Feed Additives and Human Dietary Shifts

245 papers

13.9% of this theme group

Papers advise careful assessment of bioactive feed compounds and plant‑protein replacements for health impacts.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminants and Regulatory ConcernsCautions · 04

Food Contaminants and Regulatory Concerns

240 papers

13.6% of this theme group

Works highlight safety gaps and regulatory challenges surrounding novel food ingredients and additives.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and Repair MechanismsCautions · 05

DNA Damage and Repair Mechanisms

239 papers

13.5% of this theme group

Authors note complexities in measuring genomic integrity and interpreting repair pathway data.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Antibiotic Use and Co‑Selection PressuresCautions · 06

Antibiotic Use and Co‑Selection Pressures

206 papers

11.7% of this theme group

Studies caution that antimicrobial practices can foster resistance across drugs, biocides, and metals.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance and Biological ControlCautions · 07

Pesticide Resistance and Biological Control

199 papers

11.3% of this theme group

Research points to the need for careful dosing and ecological considerations when managing pest resistance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechnologiesOpportunities · 01

Advanced Antibody and Imaging Technologies

1,044 papers

17.4% of this theme group

Papers explore novel antibody formats and fluorescence methods for in‑vivo diagnostics and cell analysis.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Modulation for Disease TherapyOpportunities · 02

Gene Modulation for Disease Therapy

1,032 papers

17.2% of this theme group

Works highlight promising strategies using knockdown, up‑regulation, and apoptosis control to treat disorders.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based Foods and AntioxidantsOpportunities · 03

Functional Plant‑Based Foods and Antioxidants

878 papers

14.6% of this theme group

Research emphasizes health‑promoting ingredients and sustainable protein sources for modern diets.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetic Editing and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic Editing and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Studies present innovative approaches to modify DNA methylation and detect disease‑related RNAs.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and Postbiotic ApplicationsOpportunities · 05

Novel Antimicrobials and Postbiotic Applications

809 papers

13.5% of this theme group

Papers describe new plant‑derived agents and microbial metabolites to combat resistance and improve animal health.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Improvement of Crop Yield TraitsOpportunities · 06

Genetic Improvement of Crop Yield Traits

717 papers

11.9% of this theme group

Research showcases advances in trait mapping, QTL analysis, and selection for higher agricultural productivity.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass Conversion and BioeconomyOpportunities · 07

Sustainable Biomass Conversion and Bioeconomy

697 papers

11.6% of this theme group

Works highlight microbial fermentation and by‑product valorization as routes to greener fuels and materials.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.6%
Promising30.4%37.4%
Breakthrough14.1%26.0%
Problem-identifying8.3%9.7%
Cautionary3.5%4.4%
Comparative2.4%3.9%
Critical1.0%1.1%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Japan

Published patent filings in the recorded source window.

Expand panel +
64,298filings 2016–2025
8,000assignees
7,237peak annual filings

Filing momentum

02,0814,1616,2428,3232016: 5,58220162017: 5,9862018: 6,19620182019: 6,4382020: 6,67820202021: 7,2372022: 6,89920222023: 6,3852024: 6,38120242025: 6,5162025

Who files the most

Chugai Pharmaceutical
6,259
Ajinomoto KK
4,106
Daiichi Sankyo
3,211
UNIV Kyoto
2,855
Toray Industries
2,746
UNIV Osaka
2,719
Takeda Pharmaceuticals
2,641
UNIV Tokyo
2,515
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Japan: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 1 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon